<DOC>
	<DOCNO>NCT01688921</DOCNO>
	<brief_summary>The purpose study determine administration seasonal flu vaccine use PharmaJet 's needle-free injection device ( STRATIS ) equivalent needle syringe administration , measure laboratory test immune response .</brief_summary>
	<brief_title>Jet Injection Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults age ≥18 ≤64 year age time enrollment Willing able give inform consent read consent form adequate opportunity discus study investigator qualify designee Willing able adhere protocol require study procedure attend schedule visit . Able receive TIV influenza vaccine , base University Colorado Health ( UCH ) employee health flu screen guideline . Stable health status exclusionary medical neuropsychiatric condition determine screen evaluation base clinical judgment investigator qualify designee . Access consistent mean telephone contact Presence febrile illness ( oral temperature &gt; 38°C ) day immunization . Such subject reevaluate enrollment resolution illness . Presence significant acute chronic uncontrolled medical neuropsychiatric illness /or presence significant condition may prohibit inclusion determine investigator qualify designee . Uncontrolled define : require institution new treatment within 1 month prior study enrollment change medication dosage month prior study enrollment . Any immunosuppressive condition include : history HIV infection , cancer cancer treatment within 3 year study enrollment , systemic glucocorticoid ( dose ≥10 mg prednisone daily equivalent 7 consecutive day 10 day total ) within 1 month study enrollment , cytotoxic immunosuppressive drug within 3 month study enrollment . Any significant disorder coagulation would increase risk intramuscular injection treatment Coumadin derivatives heparin . Known suspected allergic egg , chicken protein , gentamicin influenza vaccine . History severe previous serious adverse reaction influenza vaccination . Receipt immunoglobulin and/or blood product within 3 month immunization plan administration product study period . Prior history demyelinate disease include GuillainBarre syndrome . Presence active neurological disorder . History significant alcohol drug abuse within one year prior study enrollment . Influenza vaccination laboratory confirm influenza infection within previous six month study vaccination plan influenza vaccination study period . Planned administration noninfluenza vaccine 30 day prior study study period . Pregnant plan become pregnant study period . Currently enrol another vaccine drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Injections , Jet</keyword>
	<keyword>Influenza Vaccines</keyword>
</DOC>